Boston-based Veritas Genetics announced that it is offering Veritas myGenome, the world's first commercially available whole genome sequencing, including a secure digital report and app, interpretation and genetic counseling and access to physicians through its partnership with WorldCare International and WorldCare Consortium, for $999. The company said in an announcement today that it has signed licensing agreements with more than 100 companies worldwide who will provide their customers with MyGenome services over the next two years.
Boston-based Veritas Genetics announced that it is offering Veritas myGenome, the world's first commercially available whole genome sequencing, including a secure digital report and app, interpretation and genetic counseling and access to physicians through its partnership with WorldCare International and WorldCare Consortium, for $999. The company said that this financially accessible, ground-breaking product will make all other genetic tests irrelevant "because it is all genetic tests, and much, much more."